Celgene is committed to the enhancement of the practice of medicine and is pleased to provide a resource to healthcare practitioners treating multiple myeloma. MYeloma ALLY lets you easily navigate the diagnosis, risk stratification and monitoring guidelines of the International Myeloma Working Group (IMWG) and quickly search for MM-specific clinical trials powered by clinicaltrials.gov. In the office or on the go, MYeloma ALLY is by your side.
-Review, share and save the IMWG guidelines
-Search, share and save the MM clinical trials
MYeloma ALLY™ is a trademark of Celgene Corporation.
©2013 Celgene Corporation 10/13 US-CELG130211a